XLV Diagnostics Inc., is a Thunder Bay Regional Research Institute and TIAP medical device company based in Thunder Bay that specializes in low-cost, next-generation digital mammography machines.
The company closed a $3-million Series A investment round with Boston-based Bernard M. Gordon Charitable Remainder Unitrust. The funding will support continued product development and regulatory approval of their initial product.